Wells Fargo’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.67M Buy
273,056
+124,227
+83% +$2.12M ﹤0.01% 2287
2025
Q1
$9.5M Buy
148,829
+33,371
+29% +$2.13M ﹤0.01% 1697
2024
Q4
$14M Buy
115,458
+4,091
+4% +$497K ﹤0.01% 1428
2024
Q3
$13.9M Buy
111,367
+3,797
+4% +$474K ﹤0.01% 1421
2024
Q2
$17M Sell
107,570
-11,906
-10% -$1.88M ﹤0.01% 1241
2024
Q1
$15.5M Sell
119,476
-4,717
-4% -$611K ﹤0.01% 1281
2023
Q4
$12M Sell
124,193
-65,464
-35% -$6.31M ﹤0.01% 1418
2023
Q3
$23M Sell
189,657
-1,513
-0.8% -$183K 0.01% 949
2023
Q2
$21.9M Buy
191,170
+56,133
+42% +$6.43M 0.01% 1018
2023
Q1
$18.6M Buy
135,037
+18,775
+16% +$2.59M 0.01% 1124
2022
Q4
$15.1M Buy
116,262
+1,272
+1% +$165K ﹤0.01% 1226
2022
Q3
$12.7M Buy
114,990
+24,784
+27% +$2.74M ﹤0.01% 1284
2022
Q2
$6.76M Sell
90,206
-27,875
-24% -$2.09M ﹤0.01% 1769
2022
Q1
$9.22M Buy
118,081
+50,361
+74% +$3.93M ﹤0.01% 1817
2021
Q4
$6.1M Sell
67,720
-24,873
-27% -$2.24M ﹤0.01% 2245
2021
Q3
$8.56M Buy
92,593
+14,737
+19% +$1.36M ﹤0.01% 2264
2021
Q2
$6.05M Sell
77,856
-17,024
-18% -$1.32M ﹤0.01% 2592
2021
Q1
$7.07M Sell
94,880
-567,948
-86% -$42.3M ﹤0.01% 2405
2020
Q4
$113M Buy
662,828
+76,438
+13% +$13M 0.03% 583
2020
Q3
$82.3M Buy
586,390
+35,348
+6% +$4.96M 0.02% 640
2020
Q2
$88.4M Buy
551,042
+63,985
+13% +$10.3M 0.03% 594
2020
Q1
$47.6M Sell
487,057
-22,096
-4% -$2.16M 0.02% 777
2019
Q4
$65.7M Buy
509,153
+16,553
+3% +$2.14M 0.02% 793
2019
Q3
$37.1M Sell
492,600
-183,908
-27% -$13.9M 0.01% 1072
2019
Q2
$103M Buy
676,508
+42,463
+7% +$6.45M 0.03% 566
2019
Q1
$75.6M Buy
634,045
+10,037
+2% +$1.2M 0.02% 684
2018
Q4
$68.1M Buy
624,008
+90,108
+17% +$9.83M 0.02% 667
2018
Q3
$86.2M Buy
533,900
+177,528
+50% +$28.7M 0.02% 649
2018
Q2
$47.1M Sell
356,372
-271,676
-43% -$35.9M 0.01% 942
2018
Q1
$46.5M Buy
628,048
+340,802
+119% +$25.2M 0.01% 943
2017
Q4
$16M Sell
287,246
-13,595
-5% -$756K ﹤0.01% 1625
2017
Q3
$13.6M Buy
300,841
+192,364
+177% +$8.73M ﹤0.01% 1705
2017
Q2
$3.66M Buy
108,477
+23,767
+28% +$801K ﹤0.01% 2675
2017
Q1
$2.51M Buy
84,710
+16,620
+24% +$492K ﹤0.01% 2984
2016
Q4
$1.87M Buy
68,090
+30,093
+79% +$826K ﹤0.01% 3176
2016
Q3
$2.33M Buy
37,997
+989
+3% +$60.7K ﹤0.01% 2805
2016
Q2
$706K Buy
37,008
+51
+0.1% +$973 ﹤0.01% 3629
2016
Q1
$721K Sell
36,957
-3,618
-9% -$70.6K ﹤0.01% 3553
2015
Q4
$1.56M Sell
40,575
-109,882
-73% -$4.24M ﹤0.01% 3117
2015
Q3
$4.83M Sell
150,457
-132,180
-47% -$4.24M ﹤0.01% 2336
2015
Q2
$8.6M Sell
282,637
-13,681
-5% -$416K ﹤0.01% 2014
2015
Q1
$3.94M Buy
296,318
+19,295
+7% +$256K ﹤0.01% 2536
2014
Q4
$4.01M Buy
277,023
+240,340
+655% +$3.48M ﹤0.01% 2493
2014
Q3
$773K Buy
36,683
+11,656
+47% +$246K ﹤0.01% 3601
2014
Q2
$745K Buy
25,027
+5,671
+29% +$169K ﹤0.01% 3655
2014
Q1
$465K Sell
19,356
-1,515
-7% -$36.4K ﹤0.01% 3867
2013
Q4
$425K Sell
20,871
-51,219
-71% -$1.04M ﹤0.01% 3836
2013
Q3
$3.41M Sell
72,090
-13,919
-16% -$657K ﹤0.01% 2479
2013
Q2
$3.27M Buy
+86,009
New +$3.27M ﹤0.01% 2434